Kato (Hong Kong) Holdings Limited operates residential care homes for the elderly in Hong Kong.
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$0.65|
|52 Week High||HK$0.50|
|52 Week Low||HK$0.70|
|1 Month Change||1.56%|
|3 Month Change||1.56%|
|1 Year Change||27.45%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||16.07%|
Recent News & Updates
Kato (Hong Kong) Holdings (HKG:2189) Is Due To Pay A Dividend Of HK$0.02
Kato (Hong Kong) Holdings Limited ( HKG:2189 ) will pay a dividend of HK$0.02 on the 7th of September. This means the...
Kato (Hong Kong) Holdings (HKG:2189) Is Due To Pay A Dividend Of HK$0.02
The board of Kato (Hong Kong) Holdings Limited ( HKG:2189 ) has announced that it will pay a dividend on the 7th of...
|2189||HK Healthcare||HK Market|
Return vs Industry: 2189 exceeded the Hong Kong Healthcare industry which returned -43.7% over the past year.
Return vs Market: 2189 exceeded the Hong Kong Market which returned 5.9% over the past year.
Stable Share Price: 2189 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 2189's weekly volatility (3%) has been stable over the past year.
About the Company
Kato (Hong Kong) Holdings Limited operates residential care homes for the elderly in Hong Kong. The company provides a range of residential care services for the elderly, including accommodation, professional nursing and care-taking, nutritional management, medical, physiotherapy and occupational therapy, psychological and social care, individual care, and recreational services; and sells healthcare and medical goods, as well as offers add-on healthcare services to its residents. As of March 31, 2021, it operated eight care and attention homes for the elderly with 1,129 residential care places across four districts in Hong Kong under the Fai To, Kato, Happy Luck Home, Tsuen Wan Centre, and Pine Villa brand names.
Kato (Hong Kong) Holdings Fundamentals Summary
|2189 fundamental statistics|
Is 2189 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|2189 income statement (TTM)|
|Cost of Revenue||HK$106.63m|
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.08|
|Net Profit Margin||31.14%|
How did 2189 perform over the long term?See historical performance and comparison
6.2%Current Dividend Yield
Is Kato (Hong Kong) Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 2189 (HK$0.65) is trading below our estimate of fair value (HK$5.08)
Significantly Below Fair Value: 2189 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 2189 is good value based on its PE Ratio (8.1x) compared to the Hong Kong Healthcare industry average (16.9x).
PE vs Market: 2189 is good value based on its PE Ratio (8.1x) compared to the Hong Kong market (9.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2189's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2189 is overvalued based on its PB Ratio (2.8x) compared to the HK Healthcare industry average (1.7x).
How is Kato (Hong Kong) Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kato (Hong Kong) Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Kato (Hong Kong) Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2189 has high quality earnings.
Growing Profit Margin: 2189's current net profit margins (31.1%) are higher than last year (24.4%).
Past Earnings Growth Analysis
Earnings Trend: 2189's earnings have grown by 17.1% per year over the past 5 years.
Accelerating Growth: 2189's earnings growth over the past year (66.9%) exceeds its 5-year average (17.1% per year).
Earnings vs Industry: 2189 earnings growth over the past year (66.9%) exceeded the Healthcare industry 29.5%.
Return on Equity
High ROE: 2189's Return on Equity (34.1%) is considered high.
How is Kato (Hong Kong) Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 2189's short term assets (HK$117.3M) exceed its short term liabilities (HK$53.9M).
Long Term Liabilities: 2189's short term assets (HK$117.3M) do not cover its long term liabilities (HK$315.5M).
Debt to Equity History and Analysis
Debt Level: 2189's debt to equity ratio (51.5%) is considered high.
Reducing Debt: 2189's debt to equity ratio has reduced from 1381% to 51.5% over the past 5 years.
Debt Coverage: 2189's debt is well covered by operating cash flow (98.4%).
Interest Coverage: 2189's interest payments on its debt are well covered by EBIT (18.4x coverage).
What is Kato (Hong Kong) Holdings's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 2189's dividend (6.15%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.22%).
High Dividend: 2189's dividend (6.15%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.77%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, 2189 has been paying a dividend for less than 10 years.
Growing Dividend: 2189 has only been paying a dividend for 2 years, and since then payments have not increased.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (50.1%), 2189's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Godfrey Ngai (47 yo)
Mr. Shi Shing Ngai, also known as Godfrey, serves as Chairman of the Board at Kato (Hong Kong) Holdings Limited since October 15, 2020. He serves as an Executive Director and Chief Executive Officer of Kat...
CEO Compensation Analysis
Compensation vs Market: Godfrey's total compensation ($USD235.28K) is about average for companies of similar size in the Hong Kong market ($USD227.73K).
Compensation vs Earnings: Godfrey's compensation has increased by more than 20% in the past year.
Experienced Board: 2189's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: 2189 insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Kato (Hong Kong) Holdings Limited's employee growth, exchange listings and data sources
- Name: Kato (Hong Kong) Holdings Limited
- Ticker: 2189
- Exchange: SEHK
- Founded: 1991
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: HK$650.000m
- Shares outstanding: 1.00b
- Website: https://www.elderlyhk.com
Number of Employees
- Kato (Hong Kong) Holdings Limited
- Tung Wai Court
- 1st Floor
- Tuen Mun
- New Territories
- Hong Kong
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/25 16:59|
|End of Day Share Price||2021/10/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.